Xylem Statistics
Total Valuation
Xylem has a market cap or net worth of $30.74 billion. The enterprise value is $32.01 billion.
| Market Cap | 30.74B |
| Enterprise Value | 32.01B |
Important Dates
The next confirmed earnings date is Thursday, May 2, 2024, before market open.
| Earnings Date | May 2, 2024 |
| Ex-Dividend Date | Feb 20, 2024 |
Share Statistics
Xylem has 241.77 million shares outstanding. The number of shares has increased by 20.55% in one year.
| Shares Outstanding | 241.77M |
| Shares Change (YoY) | +20.55% |
| Shares Change (QoQ) | +0.12% |
| Owned by Insiders (%) | 0.66% |
| Owned by Institutions (%) | 95.16% |
| Float | 239.89M |
Valuation Ratios
The trailing PE ratio is 45.58 and the forward PE ratio is 30.52. Xylem's PEG ratio is 2.28.
| PE Ratio | 45.58 |
| Forward PE | 30.52 |
| PS Ratio | 4.17 |
| Forward PS | 3.58 |
| PB Ratio | 3.02 |
| P/FCF Ratio | 54.22 |
| PEG Ratio | 2.28 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 28.58, with an EV/FCF ratio of 56.45.
| EV / Earnings | 52.56 |
| EV / Sales | 4.35 |
| EV / EBITDA | 28.58 |
| EV / EBIT | 46.80 |
| EV / FCF | 56.45 |
Financial Position
The company has a current ratio of 1.76, with a Debt / Equity ratio of 0.22.
| Current Ratio | 1.76 |
| Quick Ratio | 1.20 |
| Debt / Equity | 0.22 |
| Debt / EBITDA | 2.04 |
| Debt / FCF | 4.03 |
| Interest Coverage | 13.96 |
Financial Efficiency
Return on equity (ROE) is 7.30% and return on invested capital (ROIC) is 5.02%.
| Return on Equity (ROE) | 7.30% |
| Return on Assets (ROA) | 4.30% |
| Return on Capital (ROIC) | 5.02% |
| Revenue Per Employee | $320,174 |
| Profits Per Employee | $26,478 |
| Employee Count | 23,000 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 5.12 |
Taxes
In the past 12 months, Xylem has paid $26.00 million in taxes.
| Income Tax | 26.00M |
| Effective Tax Rate | 4.09% |
Stock Price Statistics
The stock price has increased by +22.05% in the last 52 weeks. The beta is 1.10, so Xylem's price volatility has been higher than the market average.
| Beta (1Y) | 1.10 |
| 52-Week Price Change | +22.05% |
| 50-Day Moving Average | 126.80 |
| 200-Day Moving Average | 109.18 |
| Relative Strength Index (RSI) | 48.95 |
| Average Volume (30 Days) | 1,145,209 |
Short Selling Information
The latest short interest is 4.32 million, so 1.78% of the outstanding shares have been sold short.
| Short Interest | 4.32M |
| Short Previous Month | 4.34M |
| Short % of Shares Out | 1.78% |
| Short % of Float | 1.80% |
| Short Ratio (days to cover) | 4.34 |
Income Statement
In the last 12 months, Xylem had revenue of $7.36 billion and earned $609.00 million in profits. Earnings per share was $2.79.
| Revenue | 7.36B |
| Gross Profit | 2.72B |
| Operating Income | 652.00M |
| Pretax Income | 635.00M |
| Net Income | 609.00M |
| EBITDA | 1.12B |
| EBIT | 684.00M |
| Earnings Per Share (EPS) | $2.79 |
Balance Sheet
The company has $1.02 billion in cash and $2.28 billion in debt, giving a net cash position of -$1.27 billion or -$5.23 per share.
| Cash & Cash Equivalents | 1.02B |
| Total Debt | 2.28B |
| Net Cash | -1.27B |
| Net Cash Per Share | -$5.23 |
| Equity / Book Value | 10.17B |
| Book Value Per Share | 42.05 |
| Working Capital | 1.68B |
Cash Flow
In the last 12 months, operating cash flow was $837.00 million and capital expenditures -$270.00 million, giving a free cash flow of $567.00 million.
| Operating Cash Flow | 837.00M |
| Capital Expenditures | -270.00M |
| Free Cash Flow | 567.00M |
| FCF Per Share | $2.61 |
Margins
Gross margin is 36.90%, with operating and profit margins of 8.85% and 8.27%.
| Gross Margin | 36.90% |
| Operating Margin | 8.85% |
| Pretax Margin | 8.62% |
| Profit Margin | 8.27% |
| EBITDA Margin | 15.21% |
| EBIT Margin | 9.29% |
| FCF Margin | 7.70% |
Dividends & Yields
This stock pays an annual dividend of $1.44, which amounts to a dividend yield of 1.13%.
| Dividend Per Share | $1.44 |
| Dividend Yield | 1.13% |
| Dividend Growth (YoY) | 9.76% |
| Years of Dividend Growth | 12 |
| Payout Ratio | 51.61% |
| Buyback Yield | -20.55% |
| Shareholder Yield | -19.42% |
| Earnings Yield | 1.98% |
| FCF Yield | 1.84% |
Analyst Forecast
The average price target for Xylem is $137.60, which is 8.21% higher than the current price. The consensus rating is "Buy".
| Price Target | $137.60 |
| Price Target Difference | 8.21% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 8.18% |
| EPS Growth Forecast (5Y) | 20.43% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Xylem has an Altman Z-Score of 4.06 and a Piotroski F-Score of 4.
| Altman Z-Score | 4.06 |
| Piotroski F-Score | 4 |